Green Valley Drugs Recalls Hydroxocobalamin Injection Due to Sterility Concerns
Green Valley Drugs is recalling 135 vials of Hydroxocobalamin Injection nationwide due to a lack of assurance of sterility in its compounding and quality control processes.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, which corresponds to a Severe rating under the rubric for significant injury risks or structural defects, even without reported fatalities.
Plain-English summary
FVS Holdings, Inc. dba Green Valley Drugs is recalling 135 vials of Hydroxocobalamin Injection, prescription only, in all strengths and presentations. The affected products include Hydroxocobalamin 1000 mcg/mL 30mL and Hydroxocobalamin 1000 mcg/mL 10 mL P.F. The recall is being conducted nationwide.
The recall was initiated due to a lack of assurance of sterility for all sterile products compounded, repackaged, and distributed by the pharmacy. The FDA cited concerns associated with the facility's quality control processes as the reason for the action.
Consumers and healthcare providers should stop using the affected vials and contact their pharmacist or the recalling firm for further instructions. The specific lot numbers identified in the recall are 20130321-C, 20130404-H, and 20130225-H.
The recalled product
- Product
- Hydroxocobalamin Injection, all strengths and all presentations including a) Hydroxocobalamin 1000 mcg/mL 30mL and b) Hydroxocobalamin 1000 mcg/mL 10 mL P.F., Rx only, Green Valley Drugs, 1850 Whitney Mesa, #180, Henderson, NV 89014.
- Manufacturer
- FVS Holdings, Inc. dba. Green Valley Drugs
- Affected units
- 135
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- Lot #: a) Hydroxocobalamin 1000 mcg/mL 30 mL: 20130321-C
- Exp 6/21/2013
- 20130404-H
- Exp 7/3/2013
- 20130225-H
- Exp 5/25/2013
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 78 recalled by FVS Holdings, Inc. dba. Green Valley Drugs under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 78 products in this recall →Related recalls
Same manufacturer · FVS Holdings, Inc. dba. Green Valley Drugs
See all →- SevereGreen Valley Drugs Recalls Alpha Lipoic Acid Injection Due to Sterility Concerns
FDA (Drugs) · 2013-05-22
- SevereGreen Valley Drugs Recalls Phosphatidylcholine Injection Due to Sterility Concerns
FDA (Drugs) · 2013-05-22
- SevereFDA Recalls Acetylcysteine Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2013-05-22
- SevereGreen Valley Drugs Recalls Thiamine Hydrochloride Injection Due to Sterility Concerns
FDA (Drugs) · 2013-05-22
- SevereGreen Valley Drugs Recalls Folic Acid Injections Due to Sterility Concerns
FDA (Drugs) · 2013-05-22
Same hazard · sterility failure
See all →- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereROHTO DIGI-EYE Eye Drops Recalled Over Sterility Assurance Gap
FDA (Drugs) · 2026-07-29
- HighROHTO DRY-AID Eye Drops Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- SevereOne-Piece Introducer Tray kits recalled for sterility failure
FDA (Devices) · 2026-07-22
Similar recalls
- CriticalGreen Valley Drugs Recalls Cyanocobalamin Injection Due to Sterility Failure
FDA (Drugs) · 2013-05-22
- HighDowning Labs Recalls Hydroxocobalamin Injection Due to Sterility Concerns
FDA (Drugs) · 2015-11-25
- HighFallon Wellness Pharmacy Recalls Hydroxocobalamin Injections Due to Sterility Concerns
FDA (Drugs) · 2015-05-20
- SevereRXQ Compounding Recalls Hydroxocobalamin Injections Due to Sterility Concerns
FDA (Drugs) · 2019-08-14
- SevereHydroxocobalamin Injectable Recalled Due to Sterility Assurance Concerns
FDA (Drugs) · 2014-01-22
- SevereWestern Drug Recalls Hydroxocobalamin Injection Due to Sterility Concerns
FDA (Drugs) · 2015-12-09